Datum Källa Rubrik Typ Alternativ
2021-05-05 Enzymatica Kommuniké från årsstämma i Enzymatica AB (publ) den 5 maj 2021 Pressreleaser Ladda ner | Visa Stäng
2021-05-05 Enzymatica Bulletin from Annual General Meeting of Enzymatica AB (publ) on 5 May 2021 Pressreleaser Ladda ner | Visa Stäng
2021-05-05 Enzymatica Enzymatica AB: BioStock: Enzymaticas Q1-rapport visar att pandemin drabbar försäljningen Pressreleaser Visa Stäng
2021-04-29 Enzymatica Enzymatica AB: Lägre försäljning till följd av pandemin men nyemission säkerställer fortsatt internationell expansion Rapporter Ladda ner | Visa Stäng
2021-04-29 Enzymatica Enzymatica AB: Lower sales due to the pandemic but new rights issue secures continued international expansion Rapporter Ladda ner | Visa Stäng
2021-04-22 Enzymatica Enzymatica AB: BioStock: Enzymaticas styrelseordförande om nyemissionen Pressreleaser Visa Stäng
2021-03-31 Enzymatica Enzymatica AB: Enzymatica Publication of the Annual Report 2020 Rapporter Ladda ner | Visa Stäng
2021-03-31 Enzymatica Enzymatica AB: Enzymatica publicerar årsredovisningen för 2020 Rapporter Ladda ner | Visa Stäng
2021-03-31 Enzymatica Kallelse till årsstämma 2021 i Enzymatica AB (publ) Pressreleaser Ladda ner | Visa Stäng
2021-03-31 Enzymatica Notice of Annual General Meeting 2021 in Enzymatica AB (publ) Pressreleaser Ladda ner | Visa Stäng
2021-03-29 Enzymatica Enzymatica AB: Styrelsen i Enzymatica beslutar om nyemission om 59,1 MSEK Pressreleaser Ladda ner | Visa Stäng
2021-03-29 Enzymatica Enzymatica AB: Enzymatica's Board of Directors decides on a new rights issue of SEK 59.1 million Pressreleaser Ladda ner | Visa Stäng
Pressreleaser | 29 Mar 2021 | Enzymatica

Enzymatica AB: Enzymatica’s Board of Directors decides on a new rights issue of SEK 59.1 million

Background and reasons

Enzymatica is a Swedish life science company that develops and sells health care products for primarily conditions of the ear-nose-and-throat region. The products are based on a barrier technology that includes marine enzymes. The Company’s first product is the medical device ColdZyme®, a mouth spray against common cold. The product has been launched in about 30 markets on 3 continents.

ColdZyme is one of few products that addresses the cause of colds, i.e. the common cold virus. ColdZyme protects against common cold viruses, can shorten the duration of common cold if used early on, alleviates common cold symptoms and sore throat. In 2020, Enzymatica achieved several important milestones. ColdZyme was recertified, which implies that the common cold spray now is sold as a class III medical device product within the EU. Enzymatica was also granted EU-patent until 2035 for one of the key components of ColdZyme. During the year, the Company also continued to pursue its international expansion. In the beginning of the year, Enzymatica entered into an agreement with Keyuan Trade, a subsidiary of China’s second largest pharmaceutical company Shanghai Pharma, for the Chinese market. The agreement with the German company STADA was extended three times and covers now about 40 markets. In addition, Enzymatica signed an agreement with Sanofi, one of the largest pharmaceutical companies within consumer healthcare, for sales of ColdZyme in France and Italy, and with MS Pharma for sales of ColdZyme in ten selected markets within MENA – Middle East Northern Africa. Enzymatica also entered into an agreement with Chemipal, one of the leading pharmaceutical distributors in Israel.

All together, the Board of Directors of Enzymatica believes that the Company is well-positioned for continued growth that will result in rising profitability. The Company has an explicit growth strategy that is based on strengthening the position of ColdZyme in existing markets, geographical expansion through the launch of the product in additional markets, and the development of new products based on the Company’s barrier technology. The impending Rights issue will strengthen the Company’s financial position while securing the Company’s long-term investments within areas such as geographical expansion, clinical studies, organization and supply chain, and, in addition, to meet the need of working capital for 2021.

Terms and conditions in brief

Under the terms of the Rights issue, twenty nine (29) existing shares carry the right to subscribe for one (1) new share at a price of SEK 12.00 per share. The rights issue is 100 percent covered by subscription commitments (43.5 percent) and underwriting agreements (56.5 percent) from the Company’s three largest shareholders. Assuming full subscription, Enzymatica will raise SEK 59.1 million before issue expenses. Compensation for the guarantees will be paid by 7 percent of the amount guaranteed.

One (1) existing share in Enzymatica carries one (1) subscription right, while twenty nine (29) subscription rights entitle the holder to subscribe to one (1) new share. The share capital will therefore increase by a maximum of approximately SEK 196,998.20 and the number of shares by a maximum of 4,924,955 shares. The subscription price is SEK 12.00 per share.

The record date at Euroclear Sweden AB for participation in the rights issue is May 17, 2021.The subscription period will run from and including May 19, 2021 up to and including June 2, 2021.

Subscription rights not exercised by that date will expire and will lose their value. Trading in subscription rights will take place on Nasdaq First North Growth Market from and including May 19, 2021 up to and including May 28, 2021.

If not all the shares are subscribed for by exercise of subscription rights, the Board of Directors shall resolve on allotment of shares subscribed for without the exercise of subscriptions rights up to the maximum amount of the share issue. Such shares shall firstly be allotted to those who have also subscribed for shares by exercise of subscription rights, regardless of them being shareholders on the record date or not, pro rata in relation to the number of subscription rights which each person has exercised for subscription. Secondly, to others, pro rata in relation to their applied interest. To the extent that allotment in accordance to the above cannot be made pro rata, allotment shall be made by drawing of lots. Any remaining shares shall be allotted to those who have guaranteed the new share issue, pro rata in relation to the guaranteed amount.

Preliminary timetable for rights issue

May 12, 2021                                    Last day of trading in the share including subscription rights

May 14, 2021                                    First day of trading in the share excluding subscription rights

May 17, 2021                                    Record date for participation in the rights issue

May 19- June 2, 2021                      Subscription period

May 19-28, 2021                              Trading in subscription rights

June 7, 2021                                     Estimated date of announcement of the outcome of the rights issue

The Company will prepare a prospectus for the rights issue which will be published before the subscription period begins.

Adviser

Erik Penser Bank AB is Enzymatica’s financial adviser in connection with the rights issue. Mannheimer Swartling is the Company’s legal adviser.

The information in this press release is information that Enzymatica is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 8:30 CET on 29 March, 2021.

For more information, please contact:

Bengt Baron, Executive Chairman, Enzymatica AB
Phone: +46 (0)708-59 30 09 | Email: bengt.baron@outlook.com

Therese Filmersson, CFO och tf VD Enzymatica AB
Phone: +46 (0)708-40 72 24 | Email: therese.filmersson@enzymatica.com

Carl-Johan Wachtmeister, Communication manager Enzymatica AB
Phone: +46 (0)701-88 50 21 | Email: carl-johan.wachtmeister@enzymatica.com

About Enzymatica AB

Enzymatica AB is a Swedish life science company that develops and sells health care products for primarily conditions of the ear-nose-and-throat region. The products are based on a barrier technology that includes marine enzymes. The company’s first product is the medical device ColdZyme®, a mouth spray against common cold. The product has been launched in about 30 markets on 3 continents. The strategy is to continue to grow by developing more health care products and strengthening the company’s position in existing markets and expanding into new geographic markets through established partners. The company has its headquarters in Lund and is listed on Nasdaq First North Growth Market. For more information, visit: www.enzymatica.com and www.enzymatica.se/en/section/media/press-releases

Enzymatica’s certified adviser is Erik Penser Bank. Tel: +46 (0)8 463 83 00 E-mail: certifiedadviser@penser.se

2021-03-23 Enzymatica Enzymatica AB: BioStock: Enzymatica om minskad försäljning och planerad nyemission Pressreleaser Visa Stäng
2021-03-22 Enzymatica Enzymatica AB: Enzymaticas försäljning och resultat påverkat av pandemin Pressreleaser Ladda ner | Visa Stäng
2021-03-22 Enzymatica Enzymatica AB: Enzymatica's sales and result affected by the pandemic Pressreleaser Ladda ner | Visa Stäng
2021-02-23 Enzymatica Enzymatica AB: BioStock: Enzymatica har bäddat för fortsatt tillväxt Pressreleaser Visa Stäng
2021-02-18 Enzymatica Enzymatica AB: BioStock Studio: Enzymaticas ordförande om framgångarna under 2020 Pressreleaser Visa Stäng
2021-02-18 Enzymatica Enzymatica AB: Positive operating result and almost doubled sales for the fourth quarter Rapporter Ladda ner | Visa Stäng
2021-02-18 Enzymatica Enzymatica AB: Positivt rörelseresultat och nästan fördubblad försäljning för det fjärde kvartalet Rapporter Ladda ner | Visa Stäng
2021-02-11 Enzymatica Enzymatica AB: Enzymatica comments on article in Dagens Medicin Pressreleaser Ladda ner | Visa Stäng
2021-02-11 Enzymatica Enzymatica AB: Enzymatica kommenterar artikel i Dagens Medicin Pressreleaser Ladda ner | Visa Stäng
2021-01-21 Enzymatica Enzymatica AB: BioStock: Enzymaticas starka tillväxt under 2020 Pressreleaser Visa Stäng
2021-01-20 Enzymatica Enzymatica AB: BioStock: Enzymatica stärker organisationen Pressreleaser Visa Stäng
2021-01-15 Enzymatica Enzymatica AB: New strategic recruitments and organizational changes at Enzymatica Pressreleaser Ladda ner | Visa Stäng
2021-01-15 Enzymatica Enzymatica AB: Nya strategiska rekryteringar och organisations-förändring hos Enzymatica Pressreleaser Ladda ner | Visa Stäng
2020-12-10 Enzymatica Enzymatica AB: BioStock: Enzymaticas avtal med STADA utökas till att inkludera Norden Pressreleaser Visa Stäng
2020-12-09 Enzymatica Enzymatica AB: STADA agreement extended for the Nordic Region Pressreleaser Ladda ner | Visa Stäng
2020-12-09 Enzymatica Enzymatica AB: STADA-avtalet utökat med Norden Pressreleaser Ladda ner | Visa Stäng
2020-11-18 Enzymatica Enzymatica AB: BioStock: Enzymatica tecknar distributionsavtal för MENA Pressreleaser Visa Stäng
2020-11-12 Enzymatica Enzymatica AB: Enzymatica ingår avtal med MS Pharma för MENA Pressreleaser Ladda ner | Visa Stäng
2020-11-12 Enzymatica Enzymatica AB: Enzymatica enters agreement with MS Pharma for MENA Pressreleaser Ladda ner | Visa Stäng
2020-11-04 Enzymatica Enzymatica AB: BioStock: Enzymaticas försäljningsutveckling fortsatte i Q3 Pressreleaser Visa Stäng
2020-11-04 Enzymatica Penser Access: Enzymatica - Positivt kassaflöde Pressreleaser Visa Stäng
2020-11-03 Enzymatica Enzymatica AB: Continued strong sales increase and positive cash flow in third quarter Rapporter Ladda ner | Visa Stäng
2020-11-03 Enzymatica Enzymatica AB: Fortsatt stark försäljningsökning samt positivt kassaflöde under det tredje kvartalet Rapporter Ladda ner | Visa Stäng
2020-10-23 Enzymatica Enzymatica AB: BioStock: Enzymatica kommenterar avtalet med Sanofi Pressreleaser Visa Stäng
2020-10-22 Enzymatica Enzymatica AB: BioStock: Enzymaticas Sanofi-avtal öppnar för försäljning av ColdZyme i Italien och Frankrike Pressreleaser Visa Stäng
2020-10-21 Enzymatica Enzymatica AB: Enzymatica ingår avtal med Sanofi gällande Frankrike och Italien för förkylningssprayen ColdZyme Pressreleaser Ladda ner | Visa Stäng
2020-10-21 Enzymatica Enzymatica AB: Enzymatica enters agreement with Sanofi for covering France and Italy on common cold spray Coldzyme® Pressreleaser Ladda ner | Visa Stäng
2020-10-14 Enzymatica Enzymatica AB: BioStock: Enzymatica och STADA utökar avtalet för ViruProtect Pressreleaser Visa Stäng
2020-10-13 Enzymatica Enzymatica AB: Enzymatica och STADA utökar avtalet för ViruProtect till Ryssland, Polen, Ukraina och CIS-länder Pressreleaser Ladda ner | Visa Stäng
2020-10-13 Enzymatica Enzymatica AB: Enzymatica and STADA extend agreement on ViruProtect to Russia, Poland, Ukraine and CIS countries Pressreleaser Ladda ner | Visa Stäng
2020-10-07 Enzymatica Enzymatica AB: BioStock: Startskott för försäljning av ColdZyme i Israel Pressreleaser Visa Stäng
2020-10-07 Enzymatica Enzymatica AB: ColdZyme lanserad i Israel Pressreleaser Ladda ner | Visa Stäng
2020-10-07 Enzymatica Enzymatica AB: ColdZyme launched in Israel Pressreleaser Ladda ner | Visa Stäng
2020-09-28 Enzymatica Enzymatica AB: The Journal of Medical Virology has peer reviewed, approved and published the results of Enzymatica's in vitro study on SARS-CoV-2 Pressreleaser Ladda ner | Visa Stäng
2020-09-28 Enzymatica Enzymatica AB: The Journal of Medical Virology har granskat, godkänt och publicerat resultaten från Enzymaticas in vitro-studie på SARS-CoV-2 Pressreleaser Ladda ner | Visa Stäng
2020-09-24 Enzymatica Enzymatica AB: BioStock: Enzymatica erhåller patent på två stora marknader Pressreleaser Visa Stäng
2020-09-23 Enzymatica Enzymatica AB: Nya patent godkända för ColdZyme i Japan och Ryssland Pressreleaser Ladda ner | Visa Stäng
2020-09-23 Enzymatica Enzymatica AB: New patents approved for ColdZyme in Japan and Russia Pressreleaser Ladda ner | Visa Stäng
2020-09-17 Enzymatica Enzymatica AB: Ny version - rättad den 17 september 2020 Resultaten från Enzymaticas placebokontrollerade, randomiserade studie visar statistiskt signifikant kortare förkylningar. Pressreleaser Ladda ner | Visa Stäng
2020-09-17 Enzymatica Enzymatica AB: New version - corrected 17 September, 2020 The results of Enzymatica's placebo-controlled, randomized study Pressreleaser Ladda ner | Visa Stäng
2020-08-26 Enzymatica Enzymatica AB: BioStock: Enzymaticas COO kommenterar årets framgångar Pressreleaser Visa Stäng
2020-08-17 Enzymatica Enzymatica AB: Resultaten från Enzymaticas placebokontrollerade, randomiserade studie visar statistiskt signifikant kortare förkylningar och god upplevd behandlings-effekt vid användning av ColdZyme Pressreleaser Ladda ner | Visa Stäng
2020-08-17 Enzymatica Enzymatica AB: The results of Enzymatica's placebo-controlled, randomized study show statistically significant shorter common colds and good treatment efficacy when using ColdZyme Pressreleaser Ladda ner | Visa Stäng
2020-07-20 Enzymatica Enzymatica AB: BioStock: ColdZyme kan deaktivera viruset som orsakar Covid-19 Pressreleaser Visa Stäng
2020-07-20 Enzymatica Enzymatica AB: A new in vitro study shows the ability of ColdZyme to deactivate SARS-CoV-2, the cause of the COVID-19 pandemic Pressreleaser Ladda ner | Visa Stäng
2020-07-20 Enzymatica Enzymatica AB: En ny in vitro-studie visar att ColdZyme deaktiverar SARS-Cov-2 som orsakar Covid-19 pandemin Pressreleaser Ladda ner | Visa Stäng
2020-07-17 Enzymatica Enzymatica: Penser Access: Starkt kvartal men under vår förväntan Pressreleaser Visa Stäng
2020-07-16 Enzymatica Enzymatica AB: BioStock: Nytt rekordkvartal för Enzymatica Pressreleaser Visa Stäng
2020-07-16 Enzymatica Enzymatica AB: Fördubblad försäljning även under det andra kvartalet Rapporter Ladda ner | Visa Stäng
2020-07-16 Enzymatica Enzymatica AB: Doubled sales also during the second quarter Rapporter Ladda ner | Visa Stäng
2020-06-05 Enzymatica Enzymatica AB: BioStock: Nya studiedata stärker Enzymaticas case ytterligare Pressreleaser Visa Stäng
2020-06-03 Enzymatica Enzymatica AB: Kortare förkylningar för elitidrottare med ColdZyme Pressreleaser Ladda ner | Visa Stäng
2020-06-03 Enzymatica Enzymatica AB: Shorter duration of common colds for endurance athletes with ColdZyme Pressreleaser Ladda ner | Visa Stäng
2020-05-27 Enzymatica Penser Access: Enzymatica - STADA växlar upp Pressreleaser Visa Stäng
2020-05-26 Enzymatica Enzymatica AB: BioStock: Nytt distributionsavtal mellan Enzymatica och STADA Pressreleaser Visa Stäng
2020-05-25 Enzymatica Enzymatica AB: Enzymatica och STADA utökar avtalet för Europa Pressreleaser Ladda ner | Visa Stäng
2020-05-25 Enzymatica Enzymatica AB: Enzymatica and STADA extend agreement for Europe Pressreleaser Ladda ner | Visa Stäng
2020-05-19 Enzymatica Enzymatica AB: Grant of European patent for ColdZyme Pressreleaser Ladda ner | Visa Stäng
2020-05-19 Enzymatica Enzymatica AB: Europapatent godkänt för ColdZyme Pressreleaser Ladda ner | Visa Stäng
2020-05-19 Enzymatica Enzymatica AB: BioStock: Enzymatica skyfflar om bolagsledningen Pressreleaser Visa Stäng
2020-05-18 Enzymatica Enzymatica AB: Changes in management at Enzymatica Pressreleaser Ladda ner | Visa Stäng
2020-05-18 Enzymatica Enzymatica AB: Ledningsförändringar i Enzymatica Pressreleaser Ladda ner | Visa Stäng
2020-05-06 Enzymatica Penser Access: Enzymatica - Fortsatt positiv påverkan från COVID-19 Pressreleaser Visa Stäng
2020-05-05 Enzymatica Bulletin from Annual General Meeting in Enzymatica AB (publ) Pressreleaser Ladda ner | Visa Stäng
2020-05-05 Enzymatica Kommuniké från årsstämma i Enzymatica AB (publ) Pressreleaser Ladda ner | Visa Stäng
2020-05-05 Enzymatica Enzymatica AB: BioStock: Enzymatica dubblar intäkterna i Q1 Pressreleaser Visa Stäng
2020-05-05 Enzymatica Enzymatica AB: Fördubblad försäljning och positivt resultat under det första kvartalet Rapporter Ladda ner | Visa Stäng
2020-05-05 Enzymatica Enzymatica AB: Doubled sales and positive earnings for the first quarter Rapporter Ladda ner | Visa Stäng
2020-04-27 Enzymatica Enzymatica AB: BioStock: Enzymatica erhåller den högsta EU-klassningen Pressreleaser Visa Stäng
2020-04-24 Enzymatica Enzymatica AB: ColdZyme re-certified to class III in the EU Pressreleaser Ladda ner | Visa Stäng
2020-04-24 Enzymatica Enzymatica AB: ColdZyme får klass III-godkännande inom EU Pressreleaser Ladda ner | Visa Stäng
2020-04-21 Enzymatica Enzymatica AB: Enzymatica möjliggör poströstning vid årsstämman 2020 Pressreleaser Ladda ner | Visa Stäng
2020-04-21 Enzymatica Enzymatica AB: Enzymatica enables postal voting at the Annual General Meeting 2020 Pressreleaser Ladda ner | Visa Stäng
2020-04-15 Enzymatica Penser Access: Enzymatica - COVID-19 boostar försäljningen Pressreleaser Visa Stäng
2020-04-03 Enzymatica Enzymatica AB: BioStock: Enzymatica rapporterar kraftigt ökad försäljning under 2019 Pressreleaser Visa Stäng
2020-04-03 Enzymatica Notice of annual general meeting 2020 in Enzymatica AB (publ) Pressreleaser Ladda ner | Visa Stäng
2020-04-03 Enzymatica Kallelse till årsstämma 2020 i Enzymatica AB (publ) Pressreleaser Ladda ner | Visa Stäng
2020-04-02 Enzymatica Enzymatica AB: Enzymatica - publication of the Annual Report 2019 Pressreleaser Ladda ner | Visa Stäng
2020-04-02 Enzymatica Enzymatica AB: Enzymatica publicerar årsredovisningen för 2019 Pressreleaser Ladda ner | Visa Stäng
2020-03-27 Enzymatica Enzymatica AB: Enzymatica gets increased sales due to the Corona situation Pressreleaser Visa Stäng
2020-03-27 Enzymatica Enzymatica AB: Enzymatica får ökad försäljning på grund av Coronasituationen Pressreleaser Ladda ner | Visa Stäng
2020-03-24 Enzymatica Enzymatica AB: BioStock: Enzymatica äntrar den israeliska marknaden Pressreleaser Visa Stäng
2020-03-20 Enzymatica Enzymatica AB: Enzymatica tecknar avtal med Chemipal för Israel Pressreleaser Ladda ner | Visa Stäng
2020-03-20 Enzymatica Enzymatica AB: Enzymatica signs agreement with Chemipal for Israel Pressreleaser Ladda ner | Visa Stäng
2020-03-06 Enzymatica Enzymatica AB: BioStock: Användare hindrar förkylning med ColdZyme Pressreleaser Visa Stäng
2020-03-03 Enzymatica Enzymatica AB: Starka resultat från preventiv användning av ColdZyme mot förkylningsvirus Pressreleaser Ladda ner | Visa Stäng
2020-03-03 Enzymatica Enzymatica AB: Strong results from preventive use of ColdZyme against common cold virus Pressreleaser Ladda ner | Visa Stäng
2020-02-14 Enzymatica Penser Access: Enzymatica - Kosmetikaverksamheten drar upp bruttomarginalen Pressreleaser Visa Stäng
2020-02-13 Enzymatica Enzymatica AB: BioStock: Enzymatica gör sitt bästa årsresultat Pressreleaser Visa Stäng
2020-02-13 Enzymatica Enzymatica AB: ColdZyme - third largest cold brand in Sweden Rapporter Ladda ner | Visa Stäng
2020-02-13 Enzymatica Enzymatica AB: ColdZyme - tredje största varumärke i Sverige inom förkylning Rapporter Ladda ner | Visa Stäng
2020-02-03 Enzymatica Enzymatica AB: BioStock: Förlängt patentskydd för Enzymatica Pressreleaser Visa Stäng
2020-02-03 Enzymatica Enzymatica AB: The European Patent Office recommends grant of a new patent covering a key ingredient in ColdZyme against the common cold Pressreleaser Ladda ner | Visa Stäng
2020-02-03 Enzymatica Enzymatica AB: Europeiska patentverket avser att bevilja ett nytt patent för en nyckelkomponent i förkylningsprodukten ColdZyme Pressreleaser Ladda ner | Visa Stäng
2020-01-28 Enzymatica Enzymatica AB: BioStock: Avgående vd tar styrelsepost i Enzymatica Pressreleaser Visa Stäng
2020-01-28 Enzymatica Enzymatica AB: Valberedningen föreslår Fredrik Lindberg till Enzymaticas styrelse Pressreleaser Ladda ner | Visa Stäng
2020-01-28 Enzymatica Enzymatica AB: The Nomination Committee proposes that Fredrik Lindberg is elected to the Board of Directors Pressreleaser Ladda ner | Visa Stäng
2020-01-23 Enzymatica Enzymatica AB: BioStock: Enzymaticas ColdZyme lanseras i Kina via affär värd 92 Mkr Pressreleaser Visa Stäng
2020-01-22 Enzymatica Enzymatica AB: Enzymatica ingår avtal med Keyuan Trade för Kina Pressreleaser Ladda ner | Visa Stäng
2020-01-22 Enzymatica Enzymatica AB: Enzymatica signs agreement with Keyuan Trade for China Pressreleaser Ladda ner | Visa Stäng
2020-01-16 Enzymatica Enzymatica AB: BioStock: Enzymaticas ColdZyme lanseras på en första marknad i Asien Pressreleaser Visa Stäng
2020-01-14 Enzymatica Enzymatica AB: ColdZyme launched in Hong Kong Pressreleaser Ladda ner | Visa Stäng
2020-01-14 Enzymatica Enzymatica AB: ColdZyme lanserad i Hong Kong Pressreleaser Ladda ner | Visa Stäng
2020-01-10 Enzymatica Enzymatica AB: BioStock: Positiva vindar följer Enzymatica in i 2020 Pressreleaser Visa Stäng
2019-12-21 Enzymatica Enzymatica AB: Rättelse: Enzymaticas VD avgår Pressreleaser Visa Stäng
2019-12-21 Enzymatica Enzymatica AB: Enzymaticas VD avgår Pressreleaser Visa Stäng
2019-12-21 Enzymatica Enzymatica AB: Enzymatica's CEO resigns Pressreleaser Visa Stäng
2019-12-13 Enzymatica Enzymatica AB: Enzymatica in agreement for enzyme formulations for the Chinese skin care market Pressreleaser Visa Stäng
2019-12-13 Enzymatica Enzymatica AB: Enzymatica sluter avtal om leverans av enzymformuleringer för den kinesiska hudvårdsmarknaden Pressreleaser Visa Stäng
2019-11-29 Enzymatica Enzymatica AB: BioStock: Enzymaticas VD om det nya avtalet med STADA Pressreleaser Visa Stäng
2019-11-28 Enzymatica Enzymatica AB: Utökat samarbete med STADA i Tyskland Pressreleaser Ladda ner | Visa Stäng
2019-11-28 Enzymatica Enzymatica AB: STADA collaboration expands in Germany Pressreleaser Visa Stäng
2019-11-13 Enzymatica Enzymatica AB: BioStock: Bengt Baron tycker att Enzymatica är på helt rätt bana Pressreleaser Visa Stäng
2019-11-08 Enzymatica Enzymatica AB: BioStock: Enzymaticas vd nöjd med Q3-resultatet Pressreleaser Visa Stäng
2019-11-06 Enzymatica Penser Access: Enzymatica - Ny smak drar upp försäljningen Pressreleaser Visa Stäng
2019-11-05 Enzymatica Enzymatica AB: Mycket stark försäljningsökning under det tredje kvartalet Rapporter Ladda ner | Visa Stäng
2019-11-05 Enzymatica Enzymatica AB: Very strong increase of sales during the third quarter Rapporter Ladda ner | Visa Stäng
2019-10-10 Enzymatica Enzymatica AB: Enzymatica rekryterar ny kvalitetschef Pressreleaser Ladda ner | Visa Stäng
2019-10-10 Enzymatica Enzymatica AB: Enzymatica recruits new Director of Quality Assurance Pressreleaser Ladda ner | Visa Stäng
2019-09-05 Enzymatica Penser Access: Enzymatica - Negativ klinisk studie Pressreleaser Visa Stäng
2019-09-04 Enzymatica Enzymatica AB: Preliminary results of Enzymatica's placebo-controlled, randomized study did not meet the primary end-point Pressreleaser Ladda ner | Visa Stäng
2019-09-04 Enzymatica Enzymatica AB: Preliminära resultat från Enzymaticas placebokontrollerade, randomiserade studie uppfyllde inte det primära målet Pressreleaser Ladda ner | Visa Stäng
2019-08-26 Enzymatica Enzymatica AB: ColdZyme lanseras med ny smak och nya produktpåståenden Pressreleaser Visa Stäng
2019-08-26 Enzymatica Enzymatica AB: ColdZyme launches with new flavor and new product claims Pressreleaser Visa Stäng
2019-07-18 Enzymatica Penser Access: Enzymatica - Sverige visar vägen Pressreleaser Visa Stäng
2019-07-17 Enzymatica Enzymatica AB: God tillväxt under Q2, främst drivet av stark försäljning i Sverige Rapporter Ladda ner | Visa Stäng
2019-07-17 Enzymatica Enzymatica AB: Good growth in Q2, driven mainly by strong sales in Sweden Rapporter Ladda ner | Visa Stäng
2019-06-20 Enzymatica Penser Access: Enzymatica - Avtal med Maren Cosmetics Pressreleaser Visa Stäng
2019-06-19 Enzymatica Enzymatica AB: Enzymatica tecknar kosmetika-avtal till ett värde av 120 MSEK över tre år med tyska bolaget Maren Pressreleaser Ladda ner | Visa Stäng
2019-06-19 Enzymatica Enzymatica AB: Enzymatica signs supply agreement with German cosmetic company Maren, amounting to a value of SEK 120 million over a period of three years Pressreleaser Ladda ner | Visa Stäng
2019-05-08 Enzymatica Enzymatica: Penser Access: Enzymetica - Placebokontrollerad studie full rekryterad Pressreleaser Visa Stäng
2019-05-07 Enzymatica Kommuniké från årsstämma I Enzymatica AB (publ) Pressreleaser Visa Stäng
2019-05-07 Enzymatica Bulletin from Annual General Meeting in Enzymatica AB (publ) Pressreleaser Visa Stäng
2019-05-07 Enzymatica Enzymatica AB: Fortsatt stark tillväxt i Sverige men lägre total försäljning under kvartalet Rapporter Ladda ner | Visa Stäng
2019-05-07 Enzymatica Enzymatica AB: Continued strong growth in Sweden, but lower total sales during the quarter Rapporter Ladda ner | Visa Stäng
2019-05-03 Enzymatica Enzymatica AB: Samtliga patienter rekryterade till Enzymaticas tyska placebokontrollerade multicenterstudie med ColdZyme Pressreleaser Visa Stäng
2019-05-03 Enzymatica Enzymatica AB: All patients enrolled in Enzymatica's German placebo-controlled multicentre study with ColdZyme Pressreleaser Visa Stäng
2019-04-16 Enzymatica Enzymatica AB: Enzymatica's cold spray launched in South Africa Pressreleaser Ladda ner | Visa Stäng
2019-04-16 Enzymatica Enzymatica AB: Enzymaticas förkylningsspray lanserad i Sydafrika Pressreleaser Ladda ner | Visa Stäng
2019-04-05 Enzymatica Enzymatica AB:Kallelse till årsstämma 2019 i Enzymatica AB (publ) Pressreleaser Visa Stäng
2019-04-05 Enzymatica Enzymatica AB:Notice of annual general meeting 2019 in Enzymatica AB (publ) Pressreleaser Visa Stäng
2019-04-01 Enzymatica Enzymatica AB: - Publication of the annual report 2018 Pressreleaser Visa Stäng
2019-04-01 Enzymatica Enzymatica AB: Enzymatica publicerar årsredovisningen för 2018 Pressreleaser Visa Stäng
2019-02-20 Enzymatica Penser Access: Enzymatica - 56% försäljningstillväxt i Sverige Pressreleaser Visa Stäng
2019-02-19 Enzymatica Enzymatica AB: Stark försäljning under fjärde kvartalet, men lägre försäljning för helåret 2018 orsakat av restriktioner i Tyskland Pressreleaser Visa Stäng
2019-02-19 Enzymatica Enzymatica AB: Strong sales in the fourth quarter, but lower sales for full-year 2018 driven by restrictions in Germany Pressreleaser Visa Stäng
2019-01-30 Enzymatica Enzymatica AB: Första patienterna inkluderade i stor placebokontrollerad multicenterstudie med ColdZyme Pressreleaser Visa Stäng
2019-01-30 Enzymatica Enzymatica AB: First patients included in large placebo-controlled multicentre study on ColdZyme Pressreleaser Visa Stäng
2019-01-25 Enzymatica Enzymatica AB: Resultat från den tyska multicenterstudien stärker och breddar ColdZymes produktpåståenden Pressreleaser Visa Stäng
2019-01-25 Enzymatica Enzymatica AB: Results from German multicentre study strengthen and broaden ColdZyme's product claims Pressreleaser Visa Stäng
2018-12-02 Enzymatica Enzymatica AB: Enzymatica raises SEK 98.7 million in completed share issue Pressreleaser Visa Stäng
2018-12-02 Enzymatica Enzymatica AB: Enzymatica tillförs 98,7 MSEK efter avslutad nyemission Pressreleaser Visa Stäng
2018-11-12 Enzymatica Enzymatica AB: Prospekt avseende Enzymaticas företrädesemission offentliggjort Pressreleaser Visa Stäng
2018-11-12 Enzymatica Enzymatica AB: Prospectus for Enzymatica's rights issue with preferential rights for existing shareholders published Pressreleaser Visa Stäng
2018-11-05 Enzymatica Enzymatica AB: Kommuniké från extra bolagsstämma i Enzymatica AB (publ) Pressreleaser Visa Stäng
2018-11-05 Enzymatica Enzymatica AB: Bulletin from Extraordinary General Meeting in Enzymatica AB (publ) Pressreleaser Visa Stäng
2018-11-02 Enzymatica Enzymatica AB: Enzymatica's rights issue is secured up to 100 percent Pressreleaser Visa Stäng
2018-11-02 Enzymatica Enzymatica AB: Enzymaticas företrädesemission är säkerställd till 100 procent Pressreleaser Visa Stäng
2018-11-01 Enzymatica Penser Access: Enzymatica - Vädret & restriktioner i Tyskland dra ned försäljningen Pressreleaser Visa Stäng
2018-10-31 Enzymatica Enzymatica AB: Genombrottsavtal för Japan och lägre försäljning i Q3 på grund av restriktioner i Tyskland Pressreleaser Visa Stäng
2018-10-31 Enzymatica Enzymatica AB: Breakthrough agreement for Japan and lower sales in Q3 due to restrictions in Germany Pressreleaser Visa Stäng
2018-10-18 Enzymatica Enzymatica AB: Kallelse till extra bolagsstämma i Enzymatica AB (publ) Pressreleaser Visa Stäng
2018-10-18 Enzymatica Enzymatica AB: Notice of Extraordinary General Meeting in Enzymatica AB (publ) Pressreleaser Visa Stäng
2018-10-18 Enzymatica Enzymatica AB: Styrelsen i Enzymatica AB beslutar om företrädesemission om 98,7 Mkr Pressreleaser Visa Stäng
2018-10-18 Enzymatica Enzymatica AB: The Board of Directors of Enzymatica AB decides on rights issue of SEK 98.7 million Pressreleaser Visa Stäng
2018-10-18 Enzymatica Enzymatica AB: Enzymatica signs agreement for the Japanese market Pressreleaser Visa Stäng
2018-10-18 Enzymatica Enzymatica AB: Enzymatica tecknar avtal för den japanska marknaden Pressreleaser Visa Stäng
2018-10-01 Enzymatica Enzymatica AB: Significant benefits from ColdZyme in a major German multicenter study evaluating different common cold symptom scales Pressreleaser Visa Stäng
2018-10-01 Enzymatica Enzymatica AB: Signifikanta fördelar med ColdZyme i en stor tysk multicenterstudie för utvärdering av olika skalor för förkylningssymptom Pressreleaser Visa Stäng
2018-08-29 Enzymatica Enzymatica AB: Appeal of court ruling on Enzymatica's cold spray in Germany Pressreleaser Visa Stäng
2018-08-29 Enzymatica Enzymatica AB: Domen mot Enzymaticas förkylningsspray i Tyskland överklagas Pressreleaser Visa Stäng
2018-07-31 Enzymatica Enzymatica AB: Enzymatica sluter avtal om ColdZyme med ABEX Pharmaceuticals för Sydafrika Pressreleaser Visa Stäng
2018-07-31 Enzymatica Enzymatica AB: Enzymatica signs agreement for ColdZyme with ABEX Pharmaceutica (Pty) Ltd for South Africa Pressreleaser Visa Stäng
2018-07-17 Enzymatica Penser Access: Enzymatica - Tidig vår förkortade förkylningssäsongen Pressreleaser Visa Stäng
2018-07-17 Enzymatica Enzymatica AB: Lägre försäljning under Q2 men 31 %-ökning för det första halvåret Pressreleaser Visa Stäng
2018-07-17 Enzymatica Enzymatica AB: Lower sales in Q2 but 31% increase for the first half of the year Pressreleaser Visa Stäng
2018-07-16 Enzymatica Enzymatica AB: Domstolsutslag lägger restriktioner på Enzymaticas förkylningsspray i Tyskland Pressreleaser Visa Stäng
2018-07-16 Enzymatica Enzymatica AB: Court ruling put restrictions on marketing of Enzymatica's cold spray in Germany Pressreleaser Visa Stäng
2018-06-07 Enzymatica Enzymatica AB: Enzymatica säkerställer finansiering av verksamheten Pressreleaser Visa Stäng
2018-06-07 Enzymatica Enzymatica AB: Enzymatica secures funding for operations Pressreleaser Visa Stäng
2018-05-22 Enzymatica Enzymatica AB: Enzymatica sluter avtal med Qualia Pharma för Grekland och Cypern Pressreleaser Visa Stäng
2018-05-22 Enzymatica Enzymatica AB: Enzymatica signs agreement with Qualia Pharma for Greece and Cyprus Pressreleaser Visa Stäng
2018-04-27 Enzymatica Penser Access: Enzymatica - STADA & svenska apotek drar upp försäljningen Pressreleaser Visa Stäng
2018-04-26 Enzymatica Enzymatica AB: Bulletin from annual general meeting 2018 in Enzymatica AB (publ) Pressreleaser Visa Stäng
2018-04-26 Enzymatica Enzymatica AB: Kommuniké från årsstämma 2018 i Enzymatica AB (publ) Pressreleaser Visa Stäng
2018-04-26 Enzymatica Enzymatica AB: Continued growth during the first quarter Pressreleaser Visa Stäng
2018-04-26 Enzymatica Enzymatica AB: Fortsatt tillväxt under det första kvartalet Pressreleaser Visa Stäng
2018-04-11 Enzymatica Enzymatica AB: Nya resultat från Enzymaticas in vitro-studie: ColdZyme inaktiverar även coronavirus Pressreleaser Visa Stäng
2018-04-11 Enzymatica Enzymatica AB: New results from Enzymatica's in vitro study: ColdZyme also deactivates corona virus Pressreleaser Visa Stäng
2018-04-09 Enzymatica Enzymatica AB: Ny ColdZyme-studie på elitidrottare bekräftar förebyggande och förkortande effekt Pressreleaser Visa Stäng
2018-04-09 Enzymatica Enzymatica AB: New ColdZyme study in elite athletes confirms preventive effect and reduced duration of illness Pressreleaser Visa Stäng
2018-03-28 Enzymatica Enzymatica AB: Enzymatica - publication of the annual report 2017 Pressreleaser Visa Stäng
2018-03-28 Enzymatica Enzymatica AB: Enzymatica publicerar årsredovisningen för 2017 Pressreleaser Visa Stäng
2018-03-21 Enzymatica Enzymatica AB: Notice of annual general meeting in Enzymatica AB (publ) Pressreleaser Visa Stäng
2018-03-21 Enzymatica Enzymatica AB: Kallelse till årsstämma i Enzymatica AB (publ) Pressreleaser Visa Stäng
2018-02-15 Enzymatica Penser Access: Enzymatica - Uppföljningsorder från STADA drar upp försäljningen Pressreleaser Visa Stäng
2018-02-14 Enzymatica Enzymatica AB: Strong growth and international breakthrough in 2017 Pressreleaser Visa Stäng
2018-02-14 Enzymatica Enzymatica AB: Stark tillväxt och internationellt genombrott under 2017 Pressreleaser Visa Stäng
2017-11-29 Enzymatica Enzymatica AB: Enzymaticas valberedning för årsstämman 2018 utsedd Pressreleaser Visa Stäng
2017-11-29 Enzymatica Enzymatica AB: Enzymatica's Nomination Committee for the Annual General Meeting 2018 appointed Pressreleaser Visa Stäng
2017-11-14 Enzymatica Enzymatica AB: Enzymatica presenterar resultat av studie: ColdZyme har förmåga att oskadliggöra vanliga förkylningsvirus Pressreleaser Visa Stäng
2017-11-14 Enzymatica Enzymatica AB: Enzymatica announces a study showing the ability of ColdZyme to deactivate major common cold viruses Pressreleaser Visa Stäng
2017-11-09 Enzymatica Enzymatica AB: Studie om ColdZyme - Den mest rekommenderade förkylningsprodukten hos apoteken Pressreleaser Visa Stäng
2017-11-09 Enzymatica Enzymatica AB: ColdZyme study - Most recommended cold product at pharmacies Pressreleaser Visa Stäng
2017-11-02 Enzymatica Penser Access: Enzymatica - Rekordförsäljning Pressreleaser Visa Stäng
2017-11-01 Enzymatica Enzymatica AB: Delårsrapport för Enzymatica AB (publ) Januari- September 2017 Rapporter Visa Stäng
2017-11-01 Enzymatica Enzymatica AB: Interim report for Enzymatica AB (publ) January-September 2017 Pressreleaser Visa Stäng
2017-10-25 Enzymatica Enzymatica AB: Bulletin from extraordinary general meeting in Enzymatica AB (publ) Pressreleaser Visa Stäng
2017-10-25 Enzymatica Enzymatica AB: Kommuniké från extra bolagsstämma i Enzymatica AB (publ) Pressreleaser Visa Stäng
2017-10-18 Enzymatica Enzymatica AB: Fullständiga artikeln från COLDPREV I-studien publicerad - stärker dokumentation för ColdZyme Pressreleaser Visa Stäng
2017-10-18 Enzymatica Enzymatica AB: Complete article from COLDPREV I study published - strengthens documentation for ColdZyme Pressreleaser Visa Stäng
2017-09-25 Enzymatica Enzymatica AB: Kallelse till extra bolagsstämma angående bland annat personaloptionsprogram i Enzymatica AB (publ) Pressreleaser Visa Stäng
2017-09-25 Enzymatica Enzymatica AB: Notice of extraordinary general meeting regarding among other things personnel option program in Enzymatica AB (publ) Pressreleaser Visa Stäng
2017-09-06 Enzymatica Enzymatica rekryterar finanschef Pressreleaser Visa Stäng
2017-09-06 Enzymatica Enzymatica recruits Chief Financial Officer Pressreleaser Visa Stäng
2017-07-20 Enzymatica Penser Access: Enzymatica - Rekordorder från STADA Pressreleaser Visa Stäng
2017-07-20 Enzymatica Enzymatica AB: Fortsatt försäljningsökning och genombrottsorder från STADA Pressreleaser Visa Stäng
2017-07-20 Enzymatica Enzymatica AB: Continued sales growth and breakthrough order from STADA Pressreleaser Visa Stäng
2017-07-18 Enzymatica Enzymatica rekryterar Chief Commercial Officer Pressreleaser Visa Stäng
2017-07-18 Enzymatica Enzymatica recruits Chief Commercial Officer Pressreleaser Visa Stäng
2017-07-14 Enzymatica Enzymatica rekryterar Chief Operating Officer Pressreleaser Visa Stäng
2017-07-14 Enzymatica Enzymatica recruits Chief Operating Officer Pressreleaser Visa Stäng
2017-06-21 Enzymatica A study of elite athletes shows that ColdZyme provides protection as evidenced by fewer sick days and lost training days, as well as improved quality of life Pressreleaser Visa Stäng
2017-06-21 Enzymatica Studie på elitidrottare visar att ColdZyme skyddar genom att ge färre sjuk- och förlorade träningsdagar samt förbättrad livskvalitet Pressreleaser Visa Stäng
2017-06-14 Enzymatica Enzymatica får rekordorder från tyska STADA Pressreleaser Visa Stäng
2017-06-14 Enzymatica Enzymatica receives record order from STADA Arzneimittel AG Pressreleaser Visa Stäng
2017-05-23 Enzymatica Bengt Jöndell fortsätter som t f CFO Pressreleaser Visa Stäng
2017-05-23 Enzymatica Bengt Jöndell continues as acting CFO Pressreleaser Visa Stäng
2017-04-21 Enzymatica Penser Access: Enzymatica - Expansionen fortsätter i Europa Pressreleaser Visa Stäng
2017-04-20 Enzymatica Enzymatica AB: Bulletin from annual general meeting 2017 in Enzymatica AB (publ) Pressreleaser Visa Stäng
2017-04-20 Enzymatica Enzymatica AB: Kommuniké från årsstämma 2017 i Enzymatica AB (publ) Pressreleaser Visa Stäng
2017-04-20 Enzymatica Enzymatica AB: Breakthrough in Germany and continued increase in sales Pressreleaser Visa Stäng
2017-04-20 Enzymatica Enzymatica AB: Genombrott i Tyskland och fortsatt ökande försäljning Pressreleaser Visa Stäng
2017-04-06 Enzymatica Enzymatica AB: Enzymatica - publication of the annual report 2016 Pressreleaser Visa Stäng
2017-04-06 Enzymatica Enzymatica AB: Enzymatica publicerar årsredovisningen för 2016 Pressreleaser Visa Stäng
2017-04-05 Enzymatica Enzymatica AB: Completing the Nomination Committee's in Enzymatica AB proposal for AGM 2017 regarding election of auditor Pressreleaser Ladda ner | Visa Stäng
2017-04-05 Enzymatica Enzymatica AB: Completing the Nomination Committee's in Enzymatica AB proposal for AGM 2017 regarding election of auditor Pressreleaser Visa Stäng
2017-04-05 Enzymatica Enzymatica AB: Komplettering av valberedningens i Enzymatica AB förslag inför årsstämman 2017 avseende val av revisor Pressreleaser Visa Stäng
2017-03-21 Enzymatica Enzymatica AB: Notice of annual general meeting in Enzymatica AB (publ) Pressreleaser Visa Stäng
2017-03-21 Enzymatica Enzymatica AB: Kallelse till årsstämma i Enzymatica AB (publ) Pressreleaser Visa Stäng
2017-02-21 Enzymatica Penser Access: Enzymatica - Tar klivet in i Tyskland Pressreleaser Visa Stäng
2017-02-16 Enzymatica Enzymatica AB: Geographic expansion and continued growth in 2016 Pressreleaser Visa Stäng
2017-02-16 Enzymatica Enzymatica AB:Geografisk expansion och fortsatt tillväxt under 2016 Pressreleaser Visa Stäng
2017-02-13 Enzymatica Enzymatica AB: Enzymatica ingår samarbetsavtal med STADA Arzneimittel AG Pressreleaser Visa Stäng
2017-02-13 Enzymatica Enzymatica AB: Enzymatica enters into partnership agreement with STADA Arzneimittel AG Pressreleaser Visa Stäng
2016-12-21 Enzymatica Enzymatica AB: Top-line results of new clinical trial Pressreleaser Ladda ner | Visa Stäng
2016-12-21 Enzymatica Enzymatica AB: Resultat från experimentell förkylningsstudie Pressreleaser Ladda ner | Visa Stäng
2016-12-19 Enzymatica Enzymatica AB: Bulletin from extraordinary general meeting in Enzymatica AB (publ) Pressreleaser Ladda ner | Visa Stäng
2016-12-19 Enzymatica Enzymatica AB: Kommuniké från extra bolagsstämma i Enzymatica AB (publ) Pressreleaser Ladda ner | Visa Stäng
2016-12-01 Enzymatica Enzymatica AB: NOTICE OF EXTRAORDINARY SHAREHOLDERS' MEETING IN ENZYMATICA AB (publ) Pressreleaser Visa Stäng
2016-12-01 Enzymatica Enzymatica AB: KALLELSE TILL EXTRA BOLAGSSTÄMMA I ENZYMATICA AB (publ) Pressreleaser Visa Stäng
2016-12-01 Enzymatica Enzymatica AB: Extraordinary shareholders' meeting on changes to the board of directors Pressreleaser Visa Stäng
2016-12-01 Enzymatica Enzymatica AB: Extra bolagsstämma om förändringar i styrelsen Pressreleaser Visa Stäng
2016-11-07 Enzymatica Penser Access: Enzymatica - Nya avtal på andra sidan jorden Pressreleaser Visa Stäng
2016-11-03 Enzymatica Enzymatica AB: ColdZyme® sales continue to perform well Pressreleaser Visa Stäng
2016-11-03 Enzymatica Enzymatica AB: Fortsatt god försäljningsutveckling för ColdZyme® Pressreleaser Visa Stäng
2016-11-02 Enzymatica Enzymatica AB: Enzymatica signs distribution agreement with Endeavour Consumer Health Pressreleaser Visa Stäng
2016-11-02 Enzymatica Enzymatica AB: Enzymatica signs distribution agreement with Endeavour Consumer Health Pressreleaser Ladda ner | Visa Stäng
2016-11-02 Enzymatica Enzymatica AB: Enzymatica tecknar distributionssavtal med Endeavour Consumer Health för Australien/Nya Zeeland Pressreleaser Visa Stäng
2016-11-02 Enzymatica Enzymatica AB: Enzymatica tecknar distributionssavtal med Endeavour Consumer Health för Australien/Nya Zeeland Pressreleaser Ladda ner | Visa Stäng
2016-08-30 Enzymatica Enzymatica AB: The board of directors in Enzymatica has resolved on a directed share issue of SEK 40.3 million Pressreleaser Visa Stäng
2016-08-30 Enzymatica Enzymatica AB: Styrelsen i Enzymatica beslutar om riktad nyemission om 40,3 miljoner kronor Pressreleaser Visa Stäng
2016-07-25 Enzymatica Penser Access: Enzymatica - 58% tillväxt under Q2 Pressreleaser Visa Stäng
2016-07-18 Enzymatica Enzymatica AB: Excellent volume growth for ColdZyme® Pressreleaser Visa Stäng
2016-07-18 Enzymatica Enzymatica AB: God volymutveckling för ColdZyme® Pressreleaser Visa Stäng
2016-05-25 Enzymatica Kommuniké från årsstämma i Enzymatica AB (publ) Pressreleaser Visa Stäng
2016-05-25 Enzymatica Bulletin from the Annual General Meeting in Enzymatica AB (publ) Pressreleaser Ladda ner | Visa Stäng
2016-05-11 Enzymatica Enzymatica's new rights issue completed - will be provided with SEK 60 million Pressreleaser Visa Stäng
2016-05-11 Enzymatica Enzymaticas företrädesemission avslutad - tillförs 60 MSEK Pressreleaser Visa Stäng
2016-05-03 Enzymatica Enzymaticas insynspersoner avser teckna för 16 MSEK i nyemissionen Pressreleaser Visa Stäng
2016-05-03 Enzymatica Enzymatica insiders plan to subscribe for SEK 16 million in new issue Pressreleaser Visa Stäng
2016-04-26 Enzymatica Kallelse till årsstämma i Enzymatica AB (publ) Pressreleaser Visa Stäng
2016-04-26 Enzymatica Notice of annual general meeting in Enzymatica AB (publ) Pressreleaser Ladda ner | Visa Stäng
2016-04-20 Enzymatica EP Access: Enzymatica - Nya marknader levererar Pressreleaser Visa Stäng
2016-04-20 Enzymatica Enzymatica publishes prospectus Pressreleaser Visa Stäng
2016-04-20 Enzymatica Enzymatica publicerar prospekt Pressreleaser Ladda ner | Visa Stäng
2016-04-20 Enzymatica Enzymatica publicerar årsredovisningen för 2015 Pressreleaser Visa Stäng
2016-04-20 Enzymatica Enzymatica - publication of the annual report 2015 Pressreleaser Visa Stäng
2016-04-18 Enzymatica Interim Report for Enzymatica AB (publ) January-March 2016 Rapporter Visa Stäng
2016-04-18 Enzymatica Delårsrapport för Enzymatica AB (publ) januari-mars 2016 Rapporter Visa Stäng
2016-04-14 Enzymatica Kommuniké från extra bolagsstämma i Enzymatica AB (publ) Pressreleaser Visa Stäng
2016-04-14 Enzymatica Bulletin from the extraordinary shareholders' meeting in Enzymatica Pressreleaser Visa Stäng
2016-04-01 Enzymatica Enzymatica completes acquisition of Zymetech and includes new board members and representative to the nomination committee Pressreleaser Visa Stäng
2016-04-01 Enzymatica Enzymatica slutför förvärvet av Zymetech med tillträde för nya styrelseledamöter och representant i valberedningen Pressreleaser Ladda ner | Visa Stäng
2016-03-24 Enzymatica Tillförordnad CFO för Enzymatica utsedd Pressreleaser Ladda ner | Visa Stäng
2016-03-24 Enzymatica Acting CFO of Enzymatica appointed Pressreleaser Ladda ner | Visa Stäng
2016-03-17 Enzymatica Enzymatica AB: Uppdaterad tidsplan för förvärvet av Zymetech och företrädesemissionen Pressreleaser Visa Stäng
2016-03-17 Enzymatica Enzymatica AB: Updated time plan for the acquisition of Zymetech and the rights issue Pressreleaser Visa Stäng
2016-03-15 Enzymatica Enzymatica announces new dates for its financial information Pressreleaser Visa Stäng
2016-03-15 Enzymatica Enzymatica offentliggör nya datum för den finansiella informationen Pressreleaser Visa Stäng
2016-03-15 Enzymatica Kallelse till extra bolagsstämma i Enzymatica AB (publ) Pressreleaser Visa Stäng
2016-03-15 Enzymatica NOTICE OF EXTRAORDINARY SHAREHOLDERS MEETING IN ENZYMATICA AB (PUBL) Pressreleaser Visa Stäng
2016-03-15 Enzymatica Styrelsen i Enzymatica beslutar om företrädesemission om 60 miljoner SEK Pressreleaser Visa Stäng
2016-03-15 Enzymatica The board of directors in Enzymatica has resolved on a rights issue of SEK 60 million Pressreleaser Ladda ner | Visa Stäng
2016-02-18 Enzymatica Enzymatica: EP Access - Förvärvar Zymetech Pressreleaser Visa Stäng
2016-02-16 Enzymatica Enzymatica AB: Strong growth in 2015 and acquisition for international expansion Pressreleaser Ladda ner | Visa Stäng
2016-02-15 Enzymatica Bulletin from the extraordinary shareholders' meeting in Enzymatica Pressreleaser Ladda ner | Visa Stäng
2016-02-15 Enzymatica Kommuniké från extra bolagsstämma i Enzymatica AB (publ) Pressreleaser Visa Stäng
2016-02-15 Enzymatica Enzymatica AB: Stark tillväxt under 2015 och förvärv för internationell expansion Pressreleaser Visa Stäng
2016-02-03 Enzymatica Enzymatica tidigarelägger sin bokslutskommuniké 2015 Pressreleaser Ladda ner | Visa Stäng
2016-02-03 Enzymatica Enzymatica moves forward its year-end report for 2015 Pressreleaser Ladda ner | Visa Stäng
2016-01-28 Enzymatica NOTICE OF EXTRAORDINARY SHAREHOLDERS' MEETING IN ENZYMATICA AB (PUBL) Pressreleaser Visa Stäng
2016-01-28 Enzymatica Kallelse till extra bolagsstämma i Enzymatica AB (publ) Pressreleaser Visa Stäng
2016-01-28 Enzymatica Enzymatica signs acquisition agreement and prepares for international expansion with new share issue Pressreleaser Visa Stäng
2016-01-28 Enzymatica Enzymatica ingår avtal om förvärv och förbereder internationell expansion genom nyemission Pressreleaser Ladda ner | Visa Stäng
2015-11-12 Enzymatica Enzymatica tecknar distributionssavtal med Esteve i Spanien Pressreleaser Visa Stäng
2015-11-12 Enzymatica Enzymatica signs distribution agreement with Esteve in Spain Pressreleaser Visa Stäng
2015-11-10 Enzymatica Enzymatica tecknar distributionsavtal med Tamro för den finska marknaden Pressreleaser Visa Stäng
2015-11-10 Enzymatica Enzymatica signs distribution agreement with Tamro for the Finnish market Pressreleaser Visa Stäng
2015-10-26 Enzymatica Enzymatica: EP Access - Fler kliniska studier är på gång Pressreleaser Visa Stäng
2015-10-20 Enzymatica Enzymatica AB: Delårsrapport för Enzymatica AB (publ) januari-september 2015 Rapporter Visa Stäng
2015-10-16 Enzymatica Enzymatica stärker närvaron i Storbritannien genom samarbete med apotekskedjan Lloyds Pressreleaser Visa Stäng
2015-10-16 Enzymatica Enzymatica strengthens its presence in the UK through collaboration with the Lloyds pharmacy chain Pressreleaser Visa Stäng
2015-08-04 Enzymatica Enzymatica: EP Access - Hemmamarknaden fortsätter att leverera Pressreleaser Visa Stäng
2015-07-21 Enzymatica Enzymatica: Delårsrapport för Enzymatica AB (publ) januari-juni 2015 Rapporter Visa Stäng
2015-06-15 Enzymatica Enzymatica ringde in bolaget på Nasdaq First North Pressreleaser Visa Stäng
2015-06-15 Enzymatica Enzymatica rang in the company at Nasdaq First North Pressreleaser Visa Stäng
2015-06-10 Enzymatica Enzymatica approved for listing on Nasdaq First North - trading to start June 15, 2015 Pressreleaser Ladda ner | Visa Stäng
2015-06-10 Enzymatica Enzymatica har godkänts för listning på Nasdaq First North - handelsstart den 15 juni 2015 Pressreleaser Ladda ner | Visa Stäng
2015-04-21 Enzymatica Enzymatica: Kommuniké från årsstämma i Enzymatica AB (publ) Pressreleaser Ladda ner | Visa Stäng
2015-04-21 Enzymatica Enzymatica: Delårsrapport för Enzymatica AB (publ) januari-mars 2015 Pressreleaser Ladda ner | Visa Stäng
2015-04-16 Enzymatica Enzymatica: Valberedningen i Enzymatica lämnar reviderat styrelseförslag som stöds av bolagets huvudägare Pressreleaser Ladda ner | Visa Stäng
2015-04-09 Enzymatica Enzymatica: Enzymatica: Meddelande angående förslag inför årsstämma Pressreleaser Ladda ner | Visa Stäng
2015-04-08 Enzymatica Enzymatica: Valberedningens förslag till styrelse Pressreleaser Ladda ner | Visa Stäng

Kommande händelser

16 Feb 2017 | Bokslutskommuniké 2016
20 Apr 2017 | Årsstämma 2016
21 Apr 2017 | Årligutdelning 2017
20 Jul 2017 | Kvartalsrapport 2017-Q2
1 Nov 2017 | Kvartalsrapport 2017-Q3
14 Feb 2018 | Bokslutskommuniké 2017
26 Apr 2018 | Årsstämma 2017
26 Apr 2018 | Kvartalsrapport 2018-Q1
27 Apr 2018 | Årligutdelning
17 Jul 2018 | Kvartalsrapport 2018-Q2
31 Oct 2018 | Kvartalsrapport 2018-Q3
19 Feb 2019 | Bokslutskommuniké 2018
7 May 2019 | Årsstämma 2018
7 May 2019 | Kvartalsrapport 2019-Q1
8 May 2019 | Årligutdelning
17 Jul 2019 | Kvartalsrapport 2019-Q2
13 Feb 2020 | Bokslutskommuniké 2019
5 May 2020 | Årsstämma 2019
5 May 2020 | Kvartalsrapport 2020-Q1
6 May 2020 | Årligutdelning
16 Jul 2020 | Kvartalsrapport 2020-Q2
3 Nov 2020 | Kvartalsrapport 2020-Q3
18 Feb 2021 | Bokslutskommuniké 2020
29 Apr 2021 | Kvartalsrapport 2021-Q1
5 May 2021 | Årsstämma 2020
6 May 2021 | Årligutdelning
16 Jul 2021 | Kvartalsrapport 2021-Q2
2 Nov 2021 | Kvartalsrapport 2021-Q3

ca.penser.se använder cookies för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder cookies. Vad är cookies?

Jag godkänner